jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Mar. 15, 2019

Dec. 31, 2022

jRCTs032180286

Robotic assisted pyeloplasty using da Vinci Surgical system Si/Xi for ureteropelvic junction stenosis in children.

Robotic assisted pyeloplasty in children.

Jan. 18, 2021

7

Mean age at surgery was 7.4 years old (range 3-10). Ureteropelvic junction obstruction is 6 left and 1 right. Robotic-assisted pyeloplasty was performed

7 patients at our institution were registered into this study

There were no adverse events in this study

< Primary endpoint > There were no adverse events. < Secondary endpoint > Mean operative time and Mean blood loss were 368 min (range 243-516) and 6 mL (range 1-15), respectively. Duration of hospital stay was mean 7 days (range 1-15)

Robotic-assisted pyeloplasty can be performed safely and successfully without any adverse events

Dec. 31, 2022

Yes

Results on the robotic-assisted pyeloplasty plan to present on pediatric surgical meetings and publish on medical journal. These never include personal identifiable data.

https://jrct.mhlw.go.jp/latest-detail/jRCTs032180286

Yamataka Atsuyuki

Juntendo University Hospital

3-1-3 Hongo, Bunkyo-ku, Tokyo

+81-3-3813-3111

yama@juntendo.ac.jp

Murakami Hiroshi

Juntendo University Hospital

3-1-3 Hongo, Bunkyo-ku, Tokyo

+81-3-3813-3111

hmuraka@juntendo.ac.jp

Complete

Aug. 31, 2017

Nov. 21, 2018
40

Interventional

non-randomized controlled trial

open(masking not used)

active control

parallel assignment

treatment purpose

Juntendo University Medical School Association Juntendo Medical Institute Pediatric Surgery / Childhood Urology and Orthopedic Surgery Pelvic ureteral transitional stenosis patients with surgery indications visited or hospitalized

Patient who the researcher judged inappropriate as the subject

1age old over
15age old under

Both

Ureteropelvic part stenosis

Use the da Vinci Surgical system when performing renal pelvic formation.

Adverse event occurrence rate: At the time of approach, consider whether there is complication after intraoperative or postoperative. Transition to laparotomy or laparoscopic surgery, blood transfusion practice, organ damage, vascular injury, postoperative bleeding, postoperative infection, pulmonary infarction, gas embolism

1) Surgical results: operation time, bleeding volume
2) postoperative course : postoperative Vital Sign, urine volume, body temperature, drainage volume, leukocytes / CRP values on days 1, 3 and 5 postoperatively, postoperative pain (VAS: Visual Analog Scale Evaluation), hospitalization period
3) Pathological examination : presence or absence of malignancy in resected bile duct
4) Overall survival period existence of death, period from surgery to death

Juntendo Hospital Certified Review Board
3-1-3,Hongo,Bunkyo-ku,Tokyo 113-8431, Tokyo

+81-3-5802-1584

crbjun@juntendo.ac.jp
Approval

Mar. 05, 2019

UMIN000035800
University hospital Medical Information Network Center (UMIN)

none

History of Changes

No Publication date
4 Dec. 31, 2022 (this page) Changes
3 Jan. 27, 2021 Detail Changes
2 April. 16, 2019 Detail Changes
1 Mar. 15, 2019 Detail